Patents Assigned to Taiga Biotechnologies
  • Patent number: 11667695
    Abstract: Provided herein are various processes for the improved production of antibody producing organisms, antibody producing tissues, antibody producing cells and antibodies. In certain embodiments, provided herein are methods for rapidly producing antibody producing organisms, tissues, cells and antibodies derived from humans, organisms, plants or cells that are genetically altered to over-express certain proteins.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: June 6, 2023
    Assignee: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Turner
  • Patent number: 9169462
    Abstract: Provided herein are methods for preparing differentiated cells, and the cells prepared by such methods.
    Type: Grant
    Filed: July 21, 2009
    Date of Patent: October 27, 2015
    Assignee: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Curtis Turner
  • Publication number: 20150164950
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Application
    Filed: July 19, 2013
    Publication date: June 18, 2015
    Applicant: Taiga Biotechnologies, Inc.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory A. Bird
  • Patent number: 8986702
    Abstract: Provided herein are various processes for the improved production of antibody producing organisms, antibody producing tissues, antibody producing cells and antibodies. In certain embodiments, provided herein are methods for rapidly producing antibody producing organisms, tissues, cells and antibodies derived from humans, organisms, plants or cells that are genetically altered to over-express certain proteins.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: March 24, 2015
    Assignee: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Curtis Turner
  • Publication number: 20140273212
    Abstract: Disclosed are methods for manipulating and expanding stem cell populations, including adult stem cells, the cells produced by such methods, and various protein constructs related thereto.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 18, 2014
    Applicant: Taiga Biotechnologies, Inc.
    Inventors: BRIAN CURTIS TURNER, YOSEF REFAELI, GREGORY BIRD
  • Publication number: 20140255369
    Abstract: The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 11, 2014
    Applicant: Taiga Biotechnologies, Inc.
    Inventors: Brian C. TURNER, Yosef Refaeli, Gregory A. Bird
  • Patent number: 8828723
    Abstract: Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: September 9, 2014
    Assignee: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Curtis Turner
  • Patent number: 8784825
    Abstract: Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: July 22, 2014
    Assignee: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Curtis Turner
  • Publication number: 20110263820
    Abstract: Provided herein are various processes for the improved production of antibody producing organisms, antibody producing tissues, antibody producing cells and antibodies. In certain embodiments, provided herein are methods for rapidly producing antibody producing organisms, tissues, cells and antibodies derived from humans, organisms, plants or cells that are genetically altered to over-express certain proteins.
    Type: Application
    Filed: December 7, 2010
    Publication date: October 27, 2011
    Applicant: Taiga Biotechnologies, Inc.
    Inventors: Yosef Refaeli, Brian Curtis Turner
  • Publication number: 20110218210
    Abstract: Provided herein are compounds, compositions and methods for treating disorders mediated by abnormal cellular proliferation and processes for identifying such compounds.
    Type: Application
    Filed: November 3, 2008
    Publication date: September 8, 2011
    Applicant: Taiga Biotechnologies
    Inventors: Yosef Refaeli, Brian Curtis Turner